Chemoinformaics analysis of 4-Methylpentyl benzoate
| Molecular Weight | 206.285 | nRot | 5 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 27 |
| Exact Molecular Weight | 206.131 | nRing | 1 |
| Solubility: LogS | -4.731 | nHRing | 0 |
| Solubility: LogP | 2.22 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 35.3163 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.537 |
| Synth | 3.234 |
| Natural Product Likeliness | 0.929 |
| NR-PPAR-gamma | 0.786 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.006 |
| HIA | 0.005 |
| CACO-2 | -4.929 |
| MDCK | 0.0000172 |
| BBB | 0.252 |
| PPB | 0.914934 |
| VDSS | 0.585 |
| FU | 0.027056 |
| CYP1A2-inh | 0.849 |
| CYP1A2-sub | 0.928 |
| CYP2c19-inh | 0.621 |
| CYP2c19-sub | 0.567 |
| CYP2c9-inh | 0.639 |
| CYP2c9-sub | 0.657 |
| CYP2d6-inh | 0.062 |
| CYP2d6-sub | 0.787 |
| CYP3a4-inh | 0.697 |
| CYP3a4-sub | 0.408 |
| CL | 8.344 |
| T12 | 0.396 |
| hERG | 0.2 |
| Ames | 0.712 |
| ROA | 0.795 |
| SkinSen | 0.044 |
| Carcinogencity | 0.309 |
| EI | 0.012 |
| Respiratory | 0.049 |
| NR-Aromatase | 0.907 |
| Antiviral | Yes |
| Prediction | 0.613477 |